In a pooled analysis of the SPARTAN and TITAN trials, statin use during apalutamide therapy was associated with superior overall survival (OS) but also with an increased risk for grade 3 or greater ...

Please provide your email address to receive an email when new articles are posted on . Men who have depression before prostate cancer diagnosis may have significantly greater risk for death than ...

Editor's note: The Larger Trend section has been updated. California-based Artera, a company that develops multimodal AI-based prognostic and predictive cancer tests, has been granted de novo ...

“Me encontraron càncer en la pròstata,” my father told me. “They found cancer in my prostate.” As a cancer researcher who knows very well about the high incidence and decreased survival rates of ...

ArteraAI Prostate is now an FDA-regulated software (as a medical device) to estimate long-term outcomes and predict the benefit of hormone therapy for individual patients with localized prostate ...

GG1 prostate cancer can have heterogeneous outcomes, with some patients having intermediate- or high-risk disease, challenging the notion of GG1 as uniformly low-risk. Removing the cancer label for ...

BUFFALO, N.Y. – Researchers have shown for the first time that intermittent fasting increases the efficacy of anti-androgen therapy in prostate cancer, according to a paper reporting preclinical ...

A novel study has looked at different types of treatment for prostate cancer and their side effects. It suggests that for queer men, different types of treatment may be more appropriate depending on ...

Among patients with grade group 1 prostate cancer, those belonging to higher risk groups were more likely to have adverse pathology and die from their disease. About 1 in 6 patients with grade group 1 ...

People assigned female at birth can't get prostate cancer because they don't have a prostate gland. However, women can get a rare type of cancer that develops in the Skene's glands, a pair of organs ...